Related Experiment Videos

Coronary disease and stroke in patients with large-vessel peripheral arterial disease

M H Criqui1, R D Langer, A Fronek

  • 1Department of Community and Family Medicine, University of California, San Diego School of Medicine, La Jolla.

Drugs
|January 1, 1991
PubMed

Insights

Individuals with large-vessel peripheral arterial disease (LV-PAD) face significantly higher risks for both nonfatal cardiovascular events and mortality. This increased burden affects both men and women, highlighting the systemic impact of LV-PAD.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Surgery
  • Epidemiology

Background:

  • Large-vessel peripheral arterial disease (LV-PAD) is associated with increased mortality from coronary heart disease (CHD), cardiovascular disease (CVD), and all causes.
  • Limited data exists on the risk of nonfatal cardiovascular events (morbidity) in patients with LV-PAD.

Purpose of the Study:

  • To evaluate the risk of nonfatal cardiovascular events (morbidity) and mortality in patients with LV-PAD compared to controls.
  • To assess differences in CVD morbidity and mortality between men and women with LV-PAD.

Main Methods:

  • Population-based study including 67 patients with LV-PAD and 408 control subjects.
  • Evaluation of nonfatal CHD, stroke, and total CVD events, morbidity, and mortality over a 10-year follow-up period.
  • Logistic regression models adjusted for established CVD risk factors.

Main Results:

  • LV-PAD patients exhibited a 3-fold excess of CVD morbidity at baseline compared to controls.
  • Women with LV-PAD experienced more nonfatal CVD events during follow-up, leading to comparable overall morbidity rates with men.
  • Adjusted logistic regression revealed that LV-PAD increased combined CVD morbidity and mortality 2.5-fold in men and 5-fold in women.

Conclusions:

  • The total burden of cardiovascular morbidity and mortality is substantially elevated in both men and women diagnosed with LV-PAD.
  • LV-PAD represents a critical indicator of systemic cardiovascular risk, necessitating comprehensive management strategies.
  • Gender-specific differences in event patterns exist, but overall risk is significantly heightened across both sexes.

Related Concept Videos